✕
Login
Register
Back to News
Morgan Stanley Maintains Overweight on argenx, Raises Price Target to $1180
Benzinga Newsdesk
www.benzinga.com
Positive 79.4%
Neg 0%
Neu 0%
Pos 79.4%
Morgan Stanley analyst Matthew Harrison maintains argenx (NASDAQ:
ARGX
) with a Overweight and raises the price target from $1170 to $1180.
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment